rs141089159
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000377833.10(CUBN):āc.1999A>Gā(p.Thr667Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000377833.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUBN | NM_001081.4 | c.1999A>G | p.Thr667Ala | missense_variant | 16/67 | ENST00000377833.10 | NP_001072.2 | |
CUBN | XM_011519708.3 | c.1999A>G | p.Thr667Ala | missense_variant | 16/55 | XP_011518010.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUBN | ENST00000377833.10 | c.1999A>G | p.Thr667Ala | missense_variant | 16/67 | 1 | NM_001081.4 | ENSP00000367064 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251360Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135852
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461794Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727198
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74408
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2023 | The c.1999A>G (p.T667A) alteration is located in exon 16 (coding exon 16) of the CUBN gene. This alteration results from a A to G substitution at nucleotide position 1999, causing the threonine (T) at amino acid position 667 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Imerslund-Grasbeck syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 06, 2021 | This variant has not been reported in the literature in individuals with CUBN-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is present in population databases (rs141089159, ExAC 0.009%). This sequence change replaces threonine with alanine at codon 667 of the CUBN protein (p.Thr667Ala). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and alanine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at